| MPLN Division Granted Trademark Registration |
|
Molecular Pathology Laboratory Network, Inc. (MPLN) recently announced that the United States Patent and Trademark Office (USPTO) granted trademark registration for the name of one of its divisions, Geneuity® Clinical Research Services, effective on September 15, 2009. MPLN received the official certificate of registration for the Geneuity name and logo after a lengthy application and approval process that took more than a year. MPLN received official notification from the USPTO on September 22, 2009. The registration number for the Geneuity trademark is number 3682072.Geneuity provides innovative clinical laboratory testing services for biomarker analysis and therapeutic evaluation in Preclinical through Phase III clinical trials. Geneuity specializes in custom assay design and validation for pharmaceutical and biotech companies, in vitro device manufacturers and CROs. Geneuity offers technical and professional expertise in quantitative PCR, DNA and protein multiplex analyses, single nucleotide polymorphism (SNP) characterization, DNA sequencing, gene expression analysis, immunohistochemistry, flow cytometry, cytogenetics, anatomic pathology and routine central laboratory testing. Geneuity is a division of MPLN, a privately held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, women's health, prenatal care, medical genetics and pharmacogenetics and infectious disease. Geneuity and MPLN are certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, New York, Florida and Maryland. |
